Table of Contents
ISRN Pharmaceutics
Volume 2011, Article ID 582351, 6 pages
Research Article

Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature Pigs

1Clinical Research & Drug Safety Assessment, Pacira Pharmaceuticals Inc., San Diego, CA 92121, USA
2Raleigh, NC 27613, USA
3ABC Laboratories, Columbia, MO 65201, USA
4Sinclair Research Center, LLC, Auxvasse, MO 65231, USA

Received 9 August 2011; Accepted 27 September 2011

Academic Editors: G. M. El Maghraby, J. K. Lalla, M. Moneghini, A. I. Segall, A. Shahiwala, and J. Torrado

Copyright © 2011 Brigitte M. Richard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Angst and D. R. Drover, “Pharmacology of drugs formulated with DepoFoam®: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology,” Clinical Pharmacokinetics, vol. 45, no. 12, pp. 1153–1176, 2006. View at Publisher · View at Google Scholar
  2. “DepoDur® (morphine sulfate extended- release liposome injection),” Pacira Pharmaceuticals Inc., 2008,
  3. DuocaineTM USPI (lidocaine HCl—bupivacaine HCl injection) 1% / 0.375%,” Amphastar Pharmaceuticals Inc., 2009,
  4. P. Cuvillon, E. Nouvellon, J. Ripart et al., “A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: a double-blind randomized study,” Anesthesia and Analgesia, vol. 108, no. 2, pp. 641–649, 2009. View at Publisher · View at Google Scholar · View at PubMed
  5. C. M. Bernards and D. J. Kopacz, “Effect of epinephrine on lidocaine clearance in vivo: a microdialysis study in humans,” Anesthesiology, vol. 91, no. 4, pp. 962–968, 1999. View at Publisher · View at Google Scholar
  6. I. Krikava, J. Jarkovský, P. Stourac, M. Nováková, and P. Sevcík, “The effects of lidocaine on bupivacaine-induced cardiotoxicity in the isolated rat heart,” Physiological Research, vol. 59, supplement 1, pp. S65–S69, 2010. View at Google Scholar
  7. L. Simon, N. Kariya, E. Pelle-Lancien, and J. X. Mazoit, “Bupivacaine-induced QRS prolongation is enhanced by lidocaine and by phenytoin in rabbit hearts,” Anesthesia and Analgesia, vol. 94, no. 1, pp. 203–207, 2002. View at Google Scholar
  8. B. Mets, P. K. Janicki, M. F. James, R. Erskine, and B. Sasman, “Lidocaine and bupivacaine cardiorespiratory toxicity is additive: a study in rats,” Anesthesia and Analgesia, vol. 75, no. 4, pp. 611–614, 1992. View at Google Scholar
  9. J. X. Mazoit, E. E. Orhant, O. Boico, J. P. Kantelip, and K. Samii, “Myocardial uptake of bupivacaine: I. Pharmacokinetics and pharmacodynamics of lidocaine and bupivacaine in the isolated perfused rabbit heart,” Anesthesia and Analgesia, vol. 77, no. 3, pp. 469–476, 1993. View at Google Scholar
  10. Y. Fujita, S. Endoh, T. Yasukawa, and A. Sari, “Lidocaine increases the ventricular fibrillation threshold during bupivacaine-induced cardiotoxicity in pigs,” British Journal of Anaesthesia, vol. 80, no. 2, pp. 218–222, 1998. View at Google Scholar
  11. C. W. Clarkson and L. M. Hondeghem, “Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium,” Circulation Research, vol. 56, no. 4, pp. 496–506, 1985. View at Google Scholar
  12. N. A. Monteiro-Riviere, D. G. Bristol, T. O. Manning, R. A. Rogers, and J. E. Riviere, “Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species,” Journal of Investigative Dermatology, vol. 95, no. 5, pp. 582–586, 1990. View at Google Scholar
  13. R. Perez and S. C. Davis, “Relevance of animal models for wound healing,” Wounds, vol. 20, no. 1, pp. 3–8, 2008. View at Google Scholar
  14. T. P. Sullivan, W. H. Eaglstein, S. C. Davis, and P. Mertz, “The pig as a model for human wound healing,” Wound Repair and Regeneration, vol. 9, no. 2, pp. 66–76, 2001. View at Publisher · View at Google Scholar
  16. for analgesia 2008-14-06-appendices.pdf.
  17. D. B. Scott, “Evaluation of the toxicity of local anaesthetic agents in man,” British Journal of Anaesthesia, vol. 47, no. 1, pp. 56–61, 1975. View at Google Scholar
  18. G. T. Tucker and L. E. Mather, “Clinical pharmacokinetics of local anaesthetics,” Clinical Pharmacokinetics, vol. 4, no. 4, pp. 241–278, 1979. View at Google Scholar
  19. D. J. Newton, G. A. McLeod, F. Khan, and J. J. F. Belch, “Vasoactive characteristics of bupivacaine and levobupivacaine with and without adjuvant epinephrine in peripheral human skin,” British Journal of Anaesthesia, vol. 94, no. 5, pp. 662–667, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. J. P. Guinard, R. L. Carpenter, and R. C. Morell, “Effect of local anesthetic concentration on capillary blood flow in human skin,” Regional Anesthesia, vol. 17, no. 6, pp. 317–321, 1992. View at Google Scholar
  21. R. A. Johns, C. A. DiFazio, and D. E. Longnecker, “Lidocaine constricts or dilates rat arterioles in a dose-dependent manner,” Anesthesiology, vol. 62, no. 2, pp. 141–144, 1985. View at Google Scholar
  22. R. A. Johns, W. C. Seyde, C. A. DiFazio, and D. E. Longnecker, “Dose-dependent effects of bupivacaine on rat muscle arterioles,” Anesthesiology, vol. 65, no. 2, pp. 186–191, 1986. View at Google Scholar